Charles River Laboratories International Inc (NYSE:CRL) Big Money Sentiment Change at 1.13

June 29, 2018 - By Joseph Taylor

Charles River Laboratories International, Inc. (NYSE:CRL) Corporate Logo

Charles River Laboratories International Inc’s Sentiment

In 2018 Q1 Charles River Laboratories International Inc (NYSE:CRL) big money sentiment increased to 1.13, revealed SEC filings. So its up 0.05, from 2017Q4’s 1.08. 140 funds opened new or increased stock positions, while 124 decreased and sold their stock positions in Charles River Laboratories International Inc so the sentiment is better. These funds own 44.28 million shares, that’s down from 44.57 million shares in 2017Q4. Funds holding Charles River Laboratories International Inc in top 10 decreased from 2 to 1 for a decrease of 1. In total 31 funds closed positions, 93 reduced and 96 increased. Also 44 funds bought new Charles River Laboratories International Inc stakes.

Biggest Charles River Laboratories International Inc Investors

As of 2018 Q1 Channing Capital Management Llc has 2.62% invested in Charles River Laboratories International Inc. Charles River Laboratories International Inc’s shareholder Van Berkom & Associates Inc. owns 613,141 shares as of 2018 Q1. Copper Rock Capital Partners Llc reported 301,980 shares. Ariel Investments Llc revealed 1.36 million shares position in Charles River Laboratories International Inc. The Michigan-based fund Norris Perne & French Llp Mi holds 99,543 shares or 1.55% of their stocks portfolio.

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide.The firm is valued at $5.40 billion. It operates through three divisions: Research Models and Services , Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing).42.52 is the P/E ratio. The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers.

The stock increased 1.32% or $1.47 during the last trading session, hitting $112.69.Currently Charles River Laboratories International, Inc. is uptrending after 12.87% change in last June 29, 2017. CRL has 53,270 shares volume. The stock outperformed the S&P 500 by 0.30%.

On August, 8 Charles River Laboratories International, Inc. (NYSE:CRL)’s earnings report is awaited by WallStreet, RTT reports. This year’s EPS analyst estimate is awaited to be $1.47. That is 13.95 % up compareed to $1.29 EPS for last year. If the current EPS of $1.47 is accurate, CRL’s profit could be $70.43M. After $1.38 EPS report previous quarter, Wall Street now predicts 6.52 % EPS growth of Charles River Laboratories International, Inc..

Oppenheimer & Communication has 2,676 shs for 0.01% of their capital. Smithfield Trust reported 0% of its capital in Charles River Laboratories International, Inc. (NYSE:CRL). State Teachers Retirement Systems has invested 0.03% of its capital in Charles River Laboratories International, Inc. (NYSE:CRL). Archford Capital Strategies Llc reported 0% of its capital in Charles River Laboratories International, Inc. (NYSE:CRL). Personal Advsr holds 129,954 shs or 0.22% of its capital. Northern Tru holds 0.01% of its capital in Charles River Laboratories International, Inc. (NYSE:CRL) for 412,047 shs. Ubs Asset Mngmt Americas Inc stated it has 94,627 shs or 0% of all its holdings. Verition Fund Mngmt Lc invested in 2,298 shs or 0.02% of the stock. Tiaa Cref Invest Ltd Liability Co reported 180,520 shs or 0.01% of all its holdings. Ameriprise Financial reported 188,344 shs stake. Signaturefd Ltd Liability Corp has invested 0.01% in Charles River Laboratories International, Inc. (NYSE:CRL). Gabelli Funds Limited Liability Company has invested 0.02% in Charles River Laboratories International, Inc. (NYSE:CRL). Northwestern Mutual Wealth Management holds 0% of its capital in Charles River Laboratories International, Inc. (NYSE:CRL) for 196 shs. Bb&T reported 29,131 shs. Prudential Incorporated reported 313,254 shs.

Charles River Laboratories International, Inc. had 24 selling transactions and 0 insider buys since January 2, 2018. This’s net activity of $11.12 million. On Friday, March 9 $890,100 worth of Charles River Laboratories International, Inc. (NYSE:CRL) was sold by MILNE GEORGE M JR. CHUBB STEPHEN D sold $312,172 worth of Charles River Laboratories International, Inc. (NYSE:CRL) or 2,872 shs on Thursday, February 15. On Wednesday, February 28 the insider FOSTER JAMES C sold $551,176. 1,218 Charles River Laboratories International, Inc. (NYSE:CRL) shs with value of $130,558 were sold by MASSARO GEORGE. Girshick Birgit also sold $1.08 million worth of Charles River Laboratories International, Inc. (NYSE:CRL) shs. On Wednesday, February 21 $250,741 worth of stock was sold by Barbo William D.

Charles River Laboratories International, Inc. (NYSE:CRL) Ratings Coverage

In total 10 analysts cover Charles River (NYSE:CRL). “Buy” rating has 5, “Sell” are 0, while 5 are “Hold”. 50% are bullish. 11 are the (NYSE:CRL)’s analyst reports since January 19, 2018 according to StockzIntelligence Inc. On Friday, April 20 MUFG Securities Americas Inc initiated Charles River Laboratories International, Inc. (NYSE:CRL) with “Hold” rating. On Wednesday, February 14 JP Morgan maintained Charles River Laboratories International, Inc. (NYSE:CRL) with “Overweight” rating. In Friday, June 15 report KeyBanc Capital Markets upgraded the stock to “Overweight” rating. On Wednesday, March 14 the rating was maintained by Morgan Stanley with “Equal-Weight”. On Monday, January 22 SunTrust downgraded the shares of CRL in report to “Hold” rating. On Tuesday, April 24 the firm has “Buy” rating by Jefferies given. On Tuesday, February 13 the firm has “Buy” rating by Robert W. Baird given. On Tuesday, February 13 the stock of Charles River Laboratories International, Inc. (NYSE:CRL) earned “Hold” rating by RBC Capital Markets. On Wednesday, February 14 the stock has “Buy” rating by SunTrust.

For more Charles River Laboratories International, Inc. (NYSE:CRL) news posted recently go to: Benzinga.com, Benzinga.com, 247Wallst.com, Businesswire.com or Seekingalpha.com. The titles are as follows: “Charles River Laboratories Is A Leader In Biopharma Outsourcing, KeyBanc Says In Upgrade” posted on June 15, 2018, “Benzinga’s Top Upgrades, Downgrades For June 15, 2018” on June 15, 2018, “Top Analyst Upgrades and Downgrades: Advanced Micro Devices, Delphi, Domino’s Pizza, Southwest Airlines, Square …” with a publish date: June 15, 2018, “Charles River Laboratories to Present at Jefferies and William Blair Conferences” and the last “Venture Capital Deals Of The Week: Ant Financial Gets $14B Ahead Of IPO” with publication date: June 09, 2018.

Charles River Laboratories International, Inc. (NYSE:CRL) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.